Alizyme Share Discussion Threads

[vow] 03/7/2009 10:50

So what dilution level do you think it will be Qaz? £5m so 50%?

Why 10 fold, they are only going to get £18m next year from Takeda (probably £6m in July and the rest towards the end of the year), so where is the £50m going to come from to make it 10 fold?

Why would ANY one place at a higher price when they can just buy some in open market for 3p?

[city chappy] 03/7/2009 10:46

The only comments worth reading today....................



Chronicler - 3 Jul'09 - 08:51 - 79 of 81

ant15
Under the current circumstances there is more logic in suggesting a Placing at a HIGHER PRICE than the current level because the price has only dropped to below 3p on going concern issues - which would be immediately removed by additional cash - after which the shares should return to a level which more properly reflects the potential value arising from the highly likely good results from Cetilistat Japan when the Phase 3 results are out next year.




City Chappy - 3 Jul'09 - 09:11 - 81 of 81 edit

SC that is true but surely the institutions who have already invested do not want to loose what they have already put in either, especially with the Phase 3 Japan results for Cetilistat so close and the massive upside that could bring. Any money they put in now they will probably get back 10 fold next year and get a better return on what they have previously invested. As Chron said there should also be an instant rebound in the price once the extra cash comes in.

[silverbackalpha] 03/7/2009 10:42

acc looks a better share.

[dunderheed] 03/7/2009 10:37

"I would also suggest you brush up on your own gramar before judging others, doesn't say a lot for your education level school drop out?"

I assume you were being ironic about my 'gramar'?!

Incredible - seriously - the level of education required ot get a masters?!

[silverbackalpha] 03/7/2009 10:35

Are you clinically diagnosed as insane???? LOl

The share price is 2p for ferk sake.

It looks very very ominous here. I see no directors have bought this company shares since 2007, I think that says it all. They knew what was going to happen.



Date Director Trans Amount Type Price (p) Value (�) Holding %
19-02-2007 D. Campbell BUY 25,000 ORD 85.25 21,313 78,228 0.04
19-02-2007 R. Forrest BUY 10,000 ORD 85.25 8,525 47,000 0.02
19-02-2007 R. Hickling BUY 12,500 ORD 85.25 10,656 71,954 0.04
19-02-2007 T. McCarthy BUY 25,000 ORD 85.25 21,313 1,105,000 0.55
01-12-2006 D. Campbell BUY 12,500 ORD 84 10,500 53,228 0.03
01-12-2006 W. Edge BUY 12,500 ORD 84 10,500 678,066 0.34
01-12-2006 R. Hickling BUY 12,500 ORD 84 10,500 59,454 0.03
01-12-2006 T. McCarthy BUY 50,000 ORD 84 42,000 1,080,000 0.54
01-12-2006 B. Richards BUY 50,000 ORD 84 42,000 552,301 0.28
09-08-2006 T. McCarthy BUY 25,000 ORD 93 23,250 1,030,000 0.57

[johndee] 03/7/2009 10:29

the share price indicates the company being saved from going under. SP(the market) is rarely wrong.

[silverbackalpha] 03/7/2009 10:26

This company has drained a lot:

2003

COPYRIGHT 2003 Marketletter Publications Ltd.

UK drug discovery and development group Alizyme says it is planning to raise L16.1 million ($26.3 million) with the placing of 57,542,499 new shares at 28 pence, in a placing and open offer fully underwritten jointly by Nomura and Canacord. This is the firm's first fund-raising since August 2000,...

April 2005

Alizyme, the Cambridge-based biotech developing drugs for obesity and bowel problems, has raised £33m to fund a new round of trials of its experimental products.

Alizyme, the Cambridge-based biotech developing drugs for obesity and bowel problems, has raised £33m to fund a new round of trials of its experimental products.

December 2006

Worries over a share sale had worn a third off Alizyme's value over the past couple of months, so investors welcomed news that it had successfully tapped institutions for £14.5 million. Speculators were more interested that its co-founder had decided to step down.

2008: £10m




Alizyme makes last-ditch effort to raise new funds
June 29, 2009 - 9:06am ET | By John Carroll

Free newsletter via e-mail

Contact Author
Reprint
The UK's Alizyme is mounting an 11th-hour effort to stay alive. In a statement released today the developer said that its cash reserves would only carry the company through August and that it would be forced into bankruptcy or liquidation unless it raised fresh cash.

A strategic review is underway and the company is signaling that 'significant' layoffs are coming. Investors saw the blood in the water and bailed out as fast as possible, sending the company's already battered share price down 63 percent to two pence.

Alizyme funds itself from the milestones due on its program for Colal-Pred, but "material uncertainty" has developed over the receipt of money due from the pact. Alizyme has one drug candidate that has completed a Phase III clinical trial, according to its web site, one candidate in Phase III development and a further candidate with Phase II 'proof of concept' data in its development portfolio.

[alphorn] 03/7/2009 10:09

There are plenty more AZM's about.

[silverbackalpha] 03/7/2009 09:45

Of course they dont want to lose all their money, but they wont keep pumping more money in when they pretty much been lied to I would guess. Who knows what they were told at the last fund raising of £10m big ones at no less than 50p.

Where will Alan go for money now?

I believe we need to hear that TM has been given the boot to stand any chance of raising money.

He did nothing for this company but drain the cash.

[silverbackalpha] 03/7/2009 09:43

City Chappy - 3 Jul'09 - 09:11 - 81 of 81


SC that is true but surely the institutions who have already invested do not want to loose what they have already put in either, especially with the Phase 3 Japan results for Cetilistat so close and the massive upside that could bring. Any money they put in now they will probably get back 10 fold next year and get a better return on what they have previously invested. As Chron said there should also be an instant rebound in the price once the extra cash comes in.

[city chappy] 03/7/2009 09:11

SC that is true but surely the institutions who have already invested do not want to loose what they have already put in either, especially with the Phase 3 Japan results for Cetilistat so close and the massive upside that could bring. Any money they put in now they will probably get back 10 fold next year and get a better return on what they have previously invested. As Chron said there should also be an instant rebound in the price once the extra cash comes in.

[silent cartographer] 03/7/2009 08:55

How about losing all your money ?

That's quite a big downside imo !!

[chronicler] 03/7/2009 08:51

ant15
Under the current circumstances there is more logic in suggesting a Placing at a HIGHER PRICE than the current level because the price has only dropped to below 3p on going concern issues - which would be immediately removed by additional cash - after which the shares should return to a level which more properly reflects the potential value arising from the highly likely good results from Cetilistat Japan when the Phase 3 results are out next year.

---------------

ant15 - 2 Jul'09 - 14:11 - 217 of 220

Silverbackalpha...I wouldnt have thought they would consolidate the shares. Unless it was undertaken after a placing.

UPSIDES

1. They do a placing at say 2p it cannot be less than the nominal value of the stock at present) and would see a virtual company with reserves and a high quality pipeline and potential. If its with their big investors then good news.

2. Costs have been slashed to rock bottom and you can assume that they will be taken even lower.

3. They do a share split to get a placing away for eg reducing the nominal value to maybe a 1p and placing at say 1.5p...again good news for the above reasons and because the shares would be priced to move up giving holders a bonus.

4. Maybe an open offer, though this is expensive and if they have support from institutional investors that would be a favoured route to save costs.

5.The price has already dropped to where there is solid support....The shares are tightly held and should now start to move up certainly if they resolve thcash issue.

DOWNSIDE

None for investors coming in now!!!

Hope this helps.

[dunderheed] 03/7/2009 06:29

VOW 'wtgr' I am amazed you continue to put the blame on azm predicament on RP - for christs sake he left the company years ago!! I think that says it all about the business masters degrees in UK - if you seriously think this is the case - there really must be something wrong with what you were being taught?
The Tim has had a very long time to admit he was in way above his head and moved on - you yourself felt this was 'meant' to be a temporary arrangement initially - why then - bearng in mind the limitation of the man - was it allowed to become permanenet - surely the board of the company must shoulder some of this blame or was that RP's 'fault' as well?!
I continue to state I think you got a little to close to the Tim over the years and this clouded your 'judgement'. Incredible!
This is not a personal attack - it is simply trying to address an obviously incorrect pov.

[tilmanstone] 02/7/2009 23:36

Ref post 23832: "If it ticks up again I will be tempted to buy in."
How can you be serious after the last RNS??? Theres a 90% chance this company will be in recievership by Sept 1st, why on earth would anyone buy shares now. Thats not investing its pure gambling and not a very good gamble at that. I've won and lost on AZM over the years and it's sad that we've ended up here, FWIW I think we were mis-led on numerous occasions and of all the boards I've read on ADVFN this one has to be the one most riddled with nonsense. Nonetheless if you're still holding good luck, I suspect you may need it. All IMHO and DYOR

[mad mike] 02/7/2009 21:21

VOW, you need to be more detached to be a successful investor. When you are long it is obvious (e.g. obviously Timmy's friend), when you are out it is also obvious i.e. you are much more objective).

It is a pity, that you appear not so different to QAZ.

To be fair, you are not dishonest like QAZ, but you do appear to keep poor company.

Why QAZ, needs to use four to six nicknames, is a mystery to me. Anyone that is admired/respected could never use more than one nickname.

QAZ is a fantasist, who imagines he attends AGMs, has imaginary phone calls with Board members, has an imaginary PhD, an imaginary Lexuss, an imaginary long 'hose', an imaginary wife who measures it, and imaginary trades.

Try to be more like mjneish, and thus supper objective (I recon he is one of the best on ADVFN). It might not make you lots of money, but you will feel much better about yurself when you look back in a decade or so time.

Imagine how QAZ will feel about his dreadful dishonesty, in a decade's time.

[vow] 02/7/2009 19:04

Only one more month of this and then where Qaz? You life has been centred around this one for so long, yet not once have you ever called this right.

Back to OXB ramp that to death probably.

[silverbackalpha] 02/7/2009 17:54

The downside for this stock is that it goes to zero. make no mistake, it is a better than even possibility, I would estimate it at 75%. This stock pretty much needs a miracle IMO.

No money, so company.

[silverbackalpha] 02/7/2009 17:51

"could", more like it is going to.

There is not enough cash to survive beyond that. The only hope is to raise cash somehow and cut costs massively.

There should be an announcement regarding Tim soon I would hope anyway.

If he was on over £300K per year, then he would have saved at least £100K I would suggest. He will be comfortable enough I would say, certainly more than the average person and lets face it, he was probably below average in the end IMO.

I am trying to put together a spreadsheet of just how much costs can be cut here.

[dunderheed] 02/7/2009 14:20

err just one (major!) caveat - downside - could go bust by the end of August - no cash!!